Source: International Congress 2019 – Pulmonary hypertension: clinical
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Hastings (London, United Kingdom), S. Mahboobani (London, United Kingdom), A. Kempny (London, United Kingdom), K. Dimopoulos (London, United Kingdom), C. Mccabe (London, United Kingdom), A. Devaraj (London, United Kingdom), A. Wells (London, United Kingdom), S. Wort (London, United Kingdom), L. Price (London, United Kingdom). Impact of ILD severity and subtype on outcomes in CTD-associated PAH. 4758

Member's Comments

No comment yet.

Related content which might interest you: Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Estimating the effectiveness of pulmonary rehabilitation for different severity of COPD, ILD and IPF Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Comorbidities in COPD patients are not associated to higher disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Effect of comorbidities on severity and clinical parameters of COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Impact of severity on three spirometric definitions of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Cough rate may predict disease severity in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 536s Year: 2004 APACHE II and MPMo scores in prediction of outcomes in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 83s Year: 2002 Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Functional status in high and low risk patient with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013 Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Impact and outcome of COVID-19 on SSc-ILD Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Predictors of low-level disease-specific knowledge in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020 Impact of comorbid bronchiectasis on COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008